Shuren: Lawmakers should enable voluntary alternative pathway, international reliance

Regulatory NewsRegulatory NewsDiagnostics/IVDsDigital health/SaMD/AIGovernment/legislationMedical DevicesRegulatory harmonizationRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)